Evaluate the safety and efficacy of different preparations of MSCs
MSCs derived from multiple sources have demonstrated phenotypic changes and a loss of therapeutic efficacy in autoimmune disease, ageing, obesity, and neurodegenerative diseases. Our lab focuses on identifying those differences, as well as how to reprogram “diseased MSCs”.
Fabricate human organoids with complex vasculature
We’ve developed a novel bioink with high cell viability and printability. This bioink is being used to make human organoids with complex vascular.
Examine the effects of bioactive glass on MSCs
Novel bioactive glasses are being used to treat hard and soft tissues. Despite its incredible promise in the clinic, it is unclear how the biomaterials heals tissues. This project investigates the effects of the bioactive glasses on MSCs from different sources.